Capabilities

In-house Capabilities

We have combined our unique formulation and manufacturing expertise with our state-of-the-art cGMP manufacturing facility to develop products that utilize our key nasal spray technologies

Today, Our Development and Manufacturing Specialty Revolves Around 2 Key Nasal Spray Technology Platforms

Summit develops and manufactures prescription medicines utilizing Aptar’s nasal spray technologies:

Unit dose
Image courtesy of Aptar

Unit dose

The unit dose technology is intended for single-use drug administration. It dispenses all of the vial's contents in a single nasal spray. Summit Biosciences has extensive experience in producing approved unit dose nasal sprays at commercial scale.

Bi-Dose
Image courtesy of Aptar

Bi-Dose

The bi-dose technology is intended for two sequential nasal sprays. Summit Biosciences has developed a bi-dose product candidate for a new indication of an approved drug used in clinical trials for a leading specialty pharmaceutical company.

Development & Product Support

We pride ourselves on delivering high-quality products via well-planned processes and establishing efficient and flexible methodologies for our work including:

  • Formulation Development
  • Quality Control - Chemistry
  • Quality Control - Microbiology
  • Quality & Regulatory Support
  • Stability Testing
View Products & Development Support

Our FDA and EMA Approved and DEA Registered Manufacturing Facility

We leverage our FDA approved and DEA registered state-of-the-art cGMP manufacturing facility to execute the following capabilities:

  • Contract Manufacturing
  • Materials and Supply Chain Management
  • Packaging
  • Serialization
View Manufacturing